Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day
2010

Efficacy of Lisdexamfetamine in Children with ADHD

Sample size: 129 publication Evidence: moderate

Author Information

Author(s): Wigal Sharon B, Kollins Scott H, Childress Ann C, Adeyi Ben

Primary Institution: University of California, Irvine

Hypothesis

Does lisdexamfetamine dimesylate improve ADHD symptoms in children, and are there differences based on sex and age?

Conclusion

Lisdexamfetamine is effective in reducing ADHD symptoms in both boys and girls, with medium to large effect sizes across the day.

Supporting Evidence

  • Both sexes showed improvement on all assessments at postdose time points.
  • Females showed less impairment than males for SKAMP and PERMP scores.
  • Children aged 10-12 years had less impairment in SKAMP ratings than those aged 6-9 years.
  • LDX demonstrated significant improvement vs placebo on SKAMP-D from 1.5-13 hours postdose.

Takeaway

This study shows that a medicine called lisdexamfetamine helps kids with ADHD feel better and do better in school, and it works for both boys and girls.

Methodology

Children aged 6-12 with ADHD were enrolled in a dose optimization phase followed by a randomized, double-blind, placebo-controlled crossover study.

Potential Biases

The study had a higher ratio of boys to girls, which may affect the generalizability of the findings.

Limitations

The study was not powered to make direct comparisons of subgroup differences in efficacy variables or adverse event incidence.

Participant Demographics

Participants were aged 6-12 years, with a mix of boys and girls.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1753-2000-4-32

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication